PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Hemophilia and long-term HIV infection -- is there a protective link?

2013-12-11
(Press-News.org) Contact information: Vicki Cohn
vcohn@liebertpub.com
914-740-2100 x2156
Mary Ann Liebert, Inc./Genetic Engineering News
Hemophilia and long-term HIV infection -- is there a protective link?

New Rochelle, NY, December 11, 2013—People with the genetic blood clotting disorder hemophilia who have been infected with HIV for decades have an increased proportion of immune cells in their blood that specifically target HIV. This protective immune response helps chronically infected hemophilia patients survive, even during periods of HIV activity, according to a study published in BioResearch Open Access, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the BioResearch Open Access website.

Volker Daniel and colleagues, University of Heidelberg and Kurpfalz Hospital, Germany, compared the levels of a class of HIV-reactive immune cells called CD8+ lymphocytes in the blood of hemophilia patients infected with HIV for 30 years and in health individuals. They present the results in "HIV-Specific CD8+ T Lymphocytes in Blood of Long-Term HIV-Infected Hemophilia Patients."

"Understanding the reasons for long-term clinical stability in hemophilia patients living with HIV remains an important research goal, with high clinical significance," says BioResearch Open Access Editor Jane Taylor, PhD, MRC Centre for Regenerative Medicine, University of Edinburgh, Scotland. "Using a unique cohort of patients, who have been living with HIV-1 for more than 30 years, the authors propose that it is the cellular anti-HIV-1 response in combination with anti-retroviral therapy that ensures the long-term survival of these patients."



INFORMATION:

About the Journal

BioResearch Open Access is a bimonthly peer-reviewed open access journal led by Editor-in-Chief Robert Lanza, MD, Chief Scientific Officer, Advanced Cell Technology, Inc. and Editor Jane Taylor, PhD. The Journal provides a new rapid-publication forum for a broad range of scientific topics including molecular and cellular biology, tissue engineering and biomaterials, bioengineering, regenerative medicine, stem cells, gene therapy, systems biology, genetics, biochemistry, virology, microbiology, and neuroscience. All articles are published within 4 weeks of acceptance and are fully open access and posted on PubMedCentral. All journal content is available on the BioResearch Open Access website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in promising areas of science and biomedical research, including, DNA and Cell Biology, Tissue Engineering, Stem Cells and Development, Human Gene Therapy, HGT Methods, and HGT Clinical Development, and AIDS Research and Human Retroviruses. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website (http://www.liebertpub.com).

Mary Ann Liebert, Inc.
140 Huguenot St., New Rochelle, NY 10801-5215
http://www.liebertpub.com
Phone: (914) 740-2100
(800) M-LIEBERT
Fax: (914) 740-2101



ELSE PRESS RELEASES FROM THIS DATE:

New system allows for high-accuracy, through-wall, 3-D motion tracking

2013-12-11
New system allows for high-accuracy, through-wall, 3-D motion tracking Technology could revolutionize gaming, fall detection among the elderly, and more Imagine playing a video game like Call of Duty or Battlefield and having the ability to lead your virtual ...

Precise docking sites for cells

2013-12-11
Precise docking sites for cells This news release is available in German. The Petri dish is a classical biological laboratory device, but it is no ideal living environment for many types of cells. Studies lose validity, as cell behavior on a flat plastic ...

UNL-led team finds less is more with adding graphene to nanofibers

2013-12-11
UNL-led team finds less is more with adding graphene to nanofibers Creates potential for high-performance, low-cost carbon nanofibers Lincoln, Neb., Dec. 11, 2103 -- Figuring that if some is good, more must be better, researchers have been trying to pack more ...

Negative resistivity leads to positive resistance in the presence of a magnetic field

2013-12-11
Negative resistivity leads to positive resistance in the presence of a magnetic field In a paper appearing in Nature's Scientific Reports, Dr. Ramesh Mani, professor of physics and astronomy at Georgia State University, reports that, in the presence of a magnetic ...

Even when test scores go up, some cognitive abilities don't

2013-12-11
Even when test scores go up, some cognitive abilities don't CAMBRIDGE, MA -- To evaluate school quality, states require students to take standardized tests; in many cases, passing those tests is necessary to receive a high-school diploma. These high-stakes ...

1 protein, 2 personalities: Penn team identifies new mechanism of cancer spread

2013-12-11
1 protein, 2 personalities: Penn team identifies new mechanism of cancer spread Cancer involves a breakdown of normal cell behavior. Cell reproduction and movement go haywire, causing tumors to grow and spread through the body. A new finding by University ...

Online tool aids clinicians' efforts to treat injured workers

2013-12-11
Online tool aids clinicians' efforts to treat injured workers University of Alberta researchers have developed a new web-based tool to aid health professionals in determining the right treatment course for injured workers, helping them feel better and get back ...

In search of a treatment for a rare bone cancer

2013-12-11
In search of a treatment for a rare bone cancer Johns Hopkins researchers use FDA-approved lung cancer medication to shrink chordoma in mice Johns Hopkins researchers say that a drug approved to treat lung cancer substantially shrank tumors in mice that were ...

Hipster, surfer or biker? Computers may soon be able to tell the difference

2013-12-11
Hipster, surfer or biker? Computers may soon be able to tell the difference Researchers develop algorithm that uses computer vision to identify social groups Are you a hipster, surfer or biker? What is your urban tribe? Your computer may soon be able ...

Canadian researchers lead groundbreaking discovery in deadly childhood cancer

2013-12-11
Canadian researchers lead groundbreaking discovery in deadly childhood cancer This news release is available in French. MONTREAL, December 11th, 2013 — A new study by Canadian researchers may pave the way for more effective treatment ...

LAST 30 PRESS RELEASES:

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

[Press-News.org] Hemophilia and long-term HIV infection -- is there a protective link?